Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTNR1A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | PARVA | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | B4GALT1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NOL7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | FCRL4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | TSPAN17 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | EZH2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ARSA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | GATA3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |